Congressional Research Service Reports - 7 Matching Results

Search Results

Results: 1 - 7
open access

FDA Regulation of Tobacco Products: A Policy and Legal Analysis

Description: This report examines the legislative debate over giving FDA the authority to regulate tobacco products and provides some analysis of S. 2461/H.R. 4433. It begins with an overview of the FDA’s 1996 tobacco rule that includes a summary of the agency’s arguments for asserting jurisdiction over tobacco products. That is followed by an analysis of the U.S. Supreme Court decision in FDA v. Brown & Williamson, which overturned the FDA tobacco rule. The report then reviews the 1997 proposed national to… more
Date: December 3, 2004
Creator: Redhead, C. Stephen & Feder, Jody
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Medical Marijuana: Review and Analysis of Federal and State Policies

Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Date: December 29, 2005
Creator: Eddy, Mark
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

FDA’s Authority to Ensure That Drugs Prescribed to Children Are Safe and Effective

Description: The Food and Drug Administration (FDA) has approved for adult use many drugs never tested in children. Yet clinicians often prescribe them for children believing that the safety and effectiveness demonstrated with adults probably reasonably transfers to younger patients. The data show that this is not always true. To encourage industry to develop drugs and medical devices for pediatric use, Congress has established three programs. The Food and Drug Administration Amendments Act of 2007 (FDAAA, … more
Date: December 2, 2008
Creator: Thaul, Susan
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Pandemic Flu and Medical Biodefense Countermeasure Liability Limitation

Description: This report analyzes Division C of the Department of Defense Emergency Supplemental Appropriations, P.L. 109-148, which was signed into law on December 30, 2005, and which limits liability with respect to pandemic flu and other public health countermeasures.
Date: December 5, 2006
Creator: Cohen, Henry
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Overview of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

Description: This report examines the the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, which creates a prescription drug benefit for Medicare beneficiaries and establishes a new Medicare Advantage program to replace the current Medicare+Choice program.
Date: December 6, 2004
Creator: O'Sullivan, Jennifer; Chaikind, Hinda; Tilson, Sibyl; Boulanger, Jennifer & Morgan, Paulette
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Stem Cell Research

Description: This report provides background on the research and potential applications of research that uses embryonic and adult stem cells. It also provides information about the current federal and state regulatory landscape, related Congressional and international actions, and relevant ethical concerns.
Date: December 13, 2004
Creator: Johnson, Judith A. & Williams, Erin
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
Back to Top of Screen